Sequent Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Sequent Scientific has a total shareholder equity of ₹7.4B and total debt of ₹4.5B, which brings its debt-to-equity ratio to 60.9%. Its total assets and total liabilities are ₹15.6B and ₹8.2B respectively. Sequent Scientific's EBIT is ₹867.4M making its interest coverage ratio 1.6. It has cash and short-term investments of ₹742.6M.
Key information
60.9%
Debt to equity ratio
₹4.52b
Debt
Interest coverage ratio | 1.6x |
Cash | ₹742.60m |
Equity | ₹7.42b |
Total liabilities | ₹8.20b |
Total assets | ₹15.62b |
Recent financial health updates
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt
Sep 27Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet
Mar 10Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly
Nov 22Recent updates
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt
Sep 27What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You
Sep 05Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)
Apr 05Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet
Mar 10Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?
Jan 31How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?
Jan 17Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?
Jan 05What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?
Dec 24Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?
Dec 12Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly
Nov 22Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)
Nov 10The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It
Oct 20How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?
Oct 05Financial Position Analysis
Short Term Liabilities: SEQUENT's short term assets (₹8.3B) exceed its short term liabilities (₹4.9B).
Long Term Liabilities: SEQUENT's short term assets (₹8.3B) exceed its long term liabilities (₹3.3B).
Debt to Equity History and Analysis
Debt Level: SEQUENT's net debt to equity ratio (50.9%) is considered high.
Reducing Debt: SEQUENT's debt to equity ratio has increased from 43.1% to 60.9% over the past 5 years.
Debt Coverage: SEQUENT's debt is not well covered by operating cash flow (4.6%).
Interest Coverage: SEQUENT's interest payments on its debt are not well covered by EBIT (1.6x coverage).